Founded in 2010, Biomeostasis is a leading Preclinical CRO that offers in vivo research services in the fields of Metabolic, GastroIntestinal & Muscle-Wasting Diseases.
For over 15 years, we have been assessing the Efficacy & Mechanisms of action of Health Products that address conditions such as Obesity, Diabetes, MASLD/MASH, Atherosclerosis, Binge-eating, IBD, Sarcopenia, Cachexia, Duchenne Muscular Dystrophy (DMD)...
Complementary to our in vivo pharmacology services, we offer Histology and Omics enabling deciphering the efficacy and MoA of Health Products in the metabolic, GI and muscle-wasting spaces.
Localisation : Marseille - France
Company Details
- Employees
- 8
- Founded
- 2010
- Address
- Marseille, Fr
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- biomeostasis.com
- Keywords
- preclinical, obesity, diabetes, gastrointestinal disorders, tailor-made rodent models, NAFLD, NASH, in vivo pharmacology, cachexia, muscle wasting, histology, metabolic phenotyping, IBD, Ulcerative colitis.
- HQ
- Marseille
Biomeostasis Questions
Biomeostasis's website is biomeostasis.com
Biomeostasis's LinkedIn profile is https://fr.linkedin.com/company/biomeostasis
Biomeostasis has
8 employees.
View email and phone details for 8
employees at Biomeostasis.
Biomeostasis's industry is
Research Services
Biomeostasis's top competitors are
Ipsomel,
Genxmap,
Coral Biome Pharma,
Diamidex,
Biocytex,
C4diagnostics,
Biocellvia,
Gene&greentk,
Physiogenex,
Imcheck Therapeutics.
Biomeostasis's categories are Research Services
Biomeostasis's founding year is 2010
